Literature DB >> 33587221

Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.

Axel C Mühlbacher1,2,3, Andrew Sadler4, Christin Juhnke4.   

Abstract

BACKGROUND: There are unresolved procedural and medical problems in the care of diabetes, which cause high costs for health systems. These include the inadequate glycemic adjustment, care gaps, therapeutic inertia, and a lack of motivation. Personalized diabetes management can be seen as a kind of "standard process" that provides both physicians and patients with a framework. The aim of this empirical survey is the evaluation of patient preferences regarding personalized diabetes management. The purpose of this experiment is to demonstrate the properties of the programs that are relevant for the choice of insulin-based therapy regimens for patients with type II diabetes mellitus.
METHODS: A discrete choice experiment (DCE) was applied to identify preferences for a personalized diabetes management in patients with type II diabetes mellitus. Six attributes were included. The DCE was conducted in June 2017 using a fractional factorial design, and the statistical data analysis used random effect logit models.
RESULTS: N = 227 patients (66.1% male) were included. The preference analysis showed dominance for the attribute "occurrence of severe hypoglycemias per year" [level difference (LD) 2765]. Preference analysis also showed that participants weight the "risk of myocardial infarction (over 10 years)" (LD 1.854) highest among the side effects. Within the effectiveness criterion of "change in the long-term blood glucose level (HbA1c)" a change at an initial value of 9.5% (LD 1.146) is weighted slightly higher than changes at 7.5% (LD 1.141). Within the random parameter logit estimation, all coefficients proved to be significantly different from zero at the level p ≤ 0.01. The latent class analysis shows three heterogeneous classes, each showing clearly different weights of the therapeutic properties. This results in a clear three-folding: for 1/3 of the respondents the change of the long-term blood sugar (HbA1c value) is the top objective. Another third is solely interested in the short-term effectiveness of the therapy in the sense of the occurrence of severe hypoglycemias per year. The last third of the interviewees finally focuses on the follow-up regarding cardiovascular events. Overall, there were five structural and personality traits which have an influence on the respective probability of the class membership. DISCUSSION/
CONCLUSION: This study identifies and weights the key decision-making criteria for optimal management of diabetes from the perspective of patients. It was shown that the effectiveness of a care program is the most important from the perspective of the patient and avoiding severe a hypoglycemia has the greatest influence on the choice. The risk of myocardial infarction as a follow-up disease and the long-term adjustment of the blood glucose follow the importance. In the analysis of possible subgroup differences by means of latent class analysis, it was found that three preference patterns exist within the sample. The generated preference data can be used for the design of personalized management approaches. It remains open to the extent to which expert opinions and patient preferences diverge.

Entities:  

Keywords:  Discrete choice experiment; Latent class analysis; Personalized diabetes management; Type II diabetes mellitus

Year:  2021        PMID: 33587221     DOI: 10.1007/s10198-021-01264-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  23 in total

1.  Preference measurement using conjoint methods: an empirical investigation of reliability.

Authors:  S Bryan; L Gold; R Sheldon; M Buxton
Journal:  Health Econ       Date:  2000-07       Impact factor: 3.046

2.  Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.

Authors:  Katharine Barnard; Christopher Parkin; Amanda Young; Mansoor Ashraf
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 3.  [Systematic analysis of diabetic patient care in Germany].

Authors:  S Martin; R Landgraf
Journal:  Dtsch Med Wochenschr       Date:  2005-04-29       Impact factor: 0.628

4.  Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.

Authors:  S Martin; B Schneider; L Heinemann; V Lodwig; H-J Kurth; H Kolb; W A Scherbaum
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

5.  Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice.

Authors:  Axel Mühlbacher; F Reed Johnson
Journal:  Appl Health Econ Health Policy       Date:  2016-06       Impact factor: 2.561

6.  Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment.

Authors:  Michael Aristides; Adèle R Weston; Patrick FitzGerald; Corinne Le Reun; Nikos Maniadakis
Journal:  Value Health       Date:  2004 Jul-Aug       Impact factor: 5.725

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Measuring patient preferences for colorectal cancer screening using a choice-format survey.

Authors:  Deborah A Marshall; F Reed Johnson; Kathryn A Phillips; John K Marshall; Lehana Thabane; Nathalie A Kulin
Journal:  Value Health       Date:  2007 Sep-Oct       Impact factor: 5.725

10.  Delivering early care in diabetes evaluation (DECIDE): a protocol for a randomised controlled trial to assess hospital versus home management at diagnosis in childhood diabetes.

Authors:  Julia K Townson; John W Gregory; David Cohen; Sue Channon; Nicola Harman; Justin H Davies; Justin Warner; Nicola Trevelyan; Rebecca Playle; Michael Robling; Kerenza Hood; Lesley Lowes
Journal:  BMC Pediatr       Date:  2011-01-19       Impact factor: 2.125

View more
  2 in total

1.  Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.

Authors:  Jinsong Geng; Haini Bao; Zhe Feng; Jingyi Meng; Xiaolan Yu; Hao Yu
Journal:  BMC Public Health       Date:  2022-10-05       Impact factor: 4.135

2.  Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.

Authors:  Yuyu Lv; Ru Ren; Chengxiang Tang; Kuimeng Song; Shunping Li; Haipeng Wang
Journal:  Patient Prefer Adherence       Date:  2022-08-25       Impact factor: 2.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.